+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diuretics Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5319136
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Actavis Generics
  • Aurobindo Pharma
  • Jubilant Cadista
  • Merck & Co.
  • Paddock Laboratories
  • Salix Pharmaceuticals
Diuretics Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global diuretics drugs market as it emerges from the COVID-19 shut down.



Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the diuretics drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Diuretics Drugs Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:
1) By Type: Osmotic Diuretics; Carbonic Anhydrase Inhibitors; Loop Diuretics; Thiazides & Thiazide-Like Diuretics; Aldosterone Antagonists
2) By Application: Hypertension; Glaucoma; Heart Failure; Kidney Stones
3) By Distribution: Hospital Pharmacies; Independent Pharmacies; Retail Pharmacies; Drug Stores; Online Pharmacies
4) By Route of Administration: Intravenous; Oral

Companies Mentioned: Merck & Co.; Meda Manufacturing GmbH; Pfizer Inc.; GlaxoSmithKline; Roche

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Actavis Generics
  • Aurobindo Pharma
  • Jubilant Cadista
  • Merck & Co.
  • Paddock Laboratories
  • Salix Pharmaceuticals
1. Executive Summary

2. Diuretics Drugs Market Characteristics

3. Diuretics Drugs Market Trends And Strategies

4. Impact Of COVID-19 on Diuretics Drugs

5. Diuretics Drugs Market Size And Growth
5.1. Global Diuretics Drugs Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Diuretics Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Diuretics Drugs Market Segmentation
6.1. Global Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Osmotic Diuretics
  • Carbonic Anhydrase Inhibitors
  • Loop Diuretics
  • Thiazides & Thiazide-Like Diuretics
  • Aldosterone Antagonists
6.2. Global Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hypertension
  • Glaucoma
  • Heart Failure
  • Kidney Stones
6.3. Global Diuretics Drugs Market, Segmentation By Distribution, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Independent Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
6.4. Global Diuretics Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Intravenous
  • Oral
7. Diuretics Drugs Market Regional And Country Analysis
7.1. Global Diuretics Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Diuretics Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Diuretics Drugs Market
8.1. Asia-Pacific Diuretics Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Diuretics Drugs Market
9.1. China Diuretics Drugs Market Overview
9.2. China Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Diuretics Drugs Market
10.1. India Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Diuretics Drugs Market
11.1. Japan Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Diuretics Drugs Market
12.1. Australia Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Diuretics Drugs Market
13.1. Indonesia Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Diuretics Drugs Market
14.1. South Korea Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Diuretics Drugs Market
15.1. Western Europe Diuretics Drugs Market Overview
15.2. Western Europe Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Diuretics Drugs Market
16.1. UK Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Diuretics Drugs Market
17.1. Germany Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Diuretics Drugs Market
18.4. France Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Diuretics Drugs Market
19.1. Eastern Europe Diuretics Drugs Market Overview
19.2. Eastern Europe Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Diuretics Drugs Market
20.1. Russia Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Diuretics Drugs Market
21.1. North America Diuretics Drugs Market Overview
21.2. North America Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Diuretics Drugs Market
22.1. USA Diuretics Drugs Market Overview
22.2. USA Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Diuretics Drugs Market
23.1. South America Diuretics Drugs Market Overview
23.2. South America Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Diuretics Drugs Market
24.1. Brazil Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Diuretics Drugs Market
25.1. Middle East Diuretics Drugs Market Overview
25.2. Middle East Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Diuretics Drugs Market
26.1. Africa Diuretics Drugs Market Overview
26.2. Africa Diuretics Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Diuretics Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Diuretics Drugs Market Competitive Landscape And Company Profiles
27.1. Diuretics Drugs Market Competitive Landscape
27.2. Diuretics Drugs Market Company Profiles
27.2.1. Merck & Co.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Meda Manufacturing GmbH
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Pfizer Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Glaxosmithkline
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Roche
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Diuretics Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Diuretics Drugs Market

30. Diuretics Drugs Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Actavis Generics
  • Aurobindo Pharma
  • Jubilant Cadista
  • Merck & Co.
  • Paddock Laboratories
  • Salix Pharmaceuticals
Major players in the diuretic drugs market are Merck & Co., Meda Manufacturing GmbH, Pfizer Inc., Glaxosmithkline and Roche.

The global diuretics market is expected to grow from $0.82 billion in 2020 to $0.91 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.18 billion in 2025 at a CAGR of 6.7%.

The diuretic drugs market consists of sales of diuretic drugs and related services. Diuretic drugs help increase the flow of urine by reducing concentration of sodium and chloride in the body. Diuretic drugs include diuril, microzide, indapamide.

The diuretic drugs market is restricted by the stringent regulatory policies governing the market. Several requirements are laid down by the regulatory bodies to manufacture, process and pack the drugs and the companies should abide by various compliances such as FDA's CGMP regulations; Compliance with European Medicines Agency Regulations, WHO Guidelines. For instance, the Current Good Manufacturing Practice (CGMP) regulations of FDA in the USA imposes several regulations under 21 CFR parts 314, 210 and 211, with respect to application and licensing of new and generic drugs, regulations for manufacturing, processing, packaging or holding of drugs, and requirements for finished pharmaceuticals respectively. These regulations negatively impact the growth of the market.

GlaxoSmithKline merged with Pfizer in the year 2018 for $12.7 Billion. The merger helped both the companies to deliver cash flows, stronger sales and earnings growth. The merger also helped both the companies to broaden their product portfolio. With the help of this merger, the flagship Diuretic drugs like Biduret and Biduret-L of GSK will take advantage of enhanced supply chain network of Pfizer, thus resulting in more sales of drugs. GlasxoSmithKline was established in the year 2000 and is headquartered in Brentford, United Kingdom. Pfizer was established in the year 1849 and is headquartered in New York, United States of America.

The increase in the renal and kidney disorder cases drives the diuretics drug market. In such cases, the kidney does not function properly increase the need for water-pills (diuretic drugs) to maintain a proper flow of urine. The rise in kidney disorders can be attributed to change in lifestyle such as consumption of unhealthy food high in calcium and other minerals. For example, according to the National Kidney Foundation Inc, in 2019, about 1 out of every 7 or 15% of the adult population in America have chronic kidney disease (CKD).

A new drug delivery technology called the oral nanoparticle delivery technology is developed to improve the pH and intestinal permeability of the diuretic drugs to increase the digesting capability as majority of these drugs have low water solubility and bioavailability. Drugs such as amlodipine and isradipine having low bioavailability (less number of solvent to get diluted) and high light sensitivity were delivered using Nano emulsion (dispersion that consist of oil, surfactants and aqueous phase) as a drug delivery system. Pharmacokinetics (study of how organism affects drug) data of both the drugs revealed enhanced stability and bioavailability. For instance, Nanomerics, a pharmaceutical nanotechnology drug delivery company is carrying out R&D in this technology by working on MET (Molecule Envelop Technology) Nanoparticles Oral Delivery. Also,. in 2020, a Japanese research team from Kumamoto University, developed a new nanocarrier drug delivery technology to enhance the drugs, from moving from the blood into the brain.

The manufacturers must comply with the European Medicines Agency’s scientific guidelines on quality that should be maintained in the manufacturing, processing, packaging of the drugs and help manufacturers prepare marketing authorization applications. In addition, the International Council for Harmonization (ICH) guidelines lays down Good Manufacturing Practice (ICHQ7) guide which states that all the utilities like steam, gases, compressed air, heating, ventilation and air condition could impact the quality of the product (drug). Hence, proper monitoring and actions should be executed if limits are exceeded. It has also framed guidelines for Quality Risk Management (ICHQ9) that provides all the risk management methods and tools like FMEA (Failure Mode Effects Analysis), FMECA (Failure Mode, Effects and Criticality Analysis), FTA (Fault Tree Analysis), HACCP (Hazard Analysis and Critically Control Points) and others.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Merck & Co.
  • Meda Manufacturing GmbH
  • Pfizer Inc.
  • Glaxosmithkline
  • Roche
  • Aton Pharma Inc.
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • Teva Pharmaceuticals Industries Ltd.
  • Sanofi-aventis U.S. LLC
  • Centaur Pharmaceuticals Pvt Ltd
  • Validus Pharmaceuticals LLC
  • Actavis Generics
  • Paddock Laboratories
  • LLC.
  • Perrigo Pharmaceuticals Company
  • Lundbeck Inc
  • Oak Pharmaceuticals
  • Akron
  • Salix Pharmaceuticals
  • Alembic Pharms LTD
  • Aurobindo Pharma
  • IPCA Labs Ltd
  • Jubilant Cadista
  • Mylan
  • Prinston Inc
  • Sciegen Pharma
  • Unichem
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll